DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Plendil (Felodipine) - Published Studies

 
 



Plendil Related Published Studies

Well-designed clinical trials related to Plendil (Felodipine)

Pharmacokinetics of felodipine extended-release tablets in healthy Taiwanese subjects: a retrospective review. [2011]

[Effect between felodipine plus irbesartan and felodipine plus metoprolol regimen on the sexual function in young and middle-aged women with hypertension]. [2010.08]

The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment. [2009.02.20]

Comparative study of barnidipine and felodipine in Chinese patients with essential hypertension. [2006.07]

A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice-felodipine interaction. [2006.05]

A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT). [2006.04]

Sympatho-excitatory responses to once-daily dihydropyridines in young versus older hypertensive patients: amlodipine versus felodipine extended release. [2006.01]

The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients. [2005.12]

Felodipine-metoprolol combination tablet: maintained health-related quality of life in the presence of substantial blood pressure reduction. [2005.10]

Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients. [2005.03]

Effect of menthol on the pharmacokinetics and pharmacodynamics of felodipine in healthy subjects. [2005.01]

Urinary excretion of aquaporin-2 after furosemide and felodipine in healthy humans. [2005]

Well-designed clinical trials possibly related to Plendil (Felodipine)

Pharmacotherapy review of chronic pediatric hypertension. [2011.10]

Acute angiotensin II receptor blockade improves insulin-induced microvascular function in hypertensive individuals. [2011.07]

[Therapeutic effect on essential hypertension treated with combined therapy of acupuncture and medication]. [2010.11]

[Impact of antihypertensive medication timing on degree and stability of blood pressure lowering in patients with essential hypertension] [2009.11]

Combination of amlodipine 10 mg and valsartan 160 mg lowers blood pressure in patients with hypertension not controlled by an ACE inhibitor/CCB combination. [2008.12]

Further characterization of a furanocoumarin-free grapefruit juice on drug disposition: studies with cyclosporine. [2008.04]

Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study. [2007.04.17]

Lercanidipine in the treatment of hypertension. [2007.03]

Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: a randomized controlled trial using office and home blood pressure monitoring. [2006.10]

Impaired capacity for stimulated fibrinolysis in primary hypertension is restored by antihypertensive therapy. [2006.04]

Initiation of hypertension treatment with a fixed-dose combination or its monocomponents -- does it really matter? [2006.03]

Cost implications of development of diabetes in the ALPINE study. [2006.03]

AT1 receptor antagonism improves endothelial dysfunction in postmenopausal women. [2006.01.20]

Impact of the intragastric location of extended release tablets on food interactions. [2005.11.28]

Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial. [2005.03.12]

Other research related to Plendil (Felodipine)

Rapidly absorbed orodispersible tablet containing molecularly dispersed felodipine for management of hypertensive crisis: development, optimization and in vitro/in vivo studies. [2013]

Effect of felodipine with irbesartan or metoprolol on sexual function and oxidative stress in women with essential hypertension. [2011.11.30]

Development of a high-performance liquid chromatography method for simultaneous determination of pioglitazone and felodipine in pig serum: application to pharmacokinetic study. [2011.08]

Development of bioadhesive buccal tablets for felodipine and pioglitazone in combined dosage form: in vitro, ex vivo, and in vivo characterization. [2011.07]

Pharmacokinetic and antihypertensive profile of amlodipine and felodipine-ER in younger versus older patients with hypertension. [2010.12]

Effects of individual risk factors on the residual risk of cardiovascular events in a population of treated Chinese patients with hypertension: data from the Felodipine Event Reduction (FEVER) study. [2010.10]

Pharmacokinetic and Antihypertensive Profile of Amlodipine and Felodipine-ER in Young Versus Older Hypertensives. [2010.09.25]

Publication bias on clinical studies of pharmacokinetic interactions between felodipine and grapefruit juice. [2010.05]

Effect of felodipine on myocardial and renal injury induced by aldosterone-high salt hypertension in uninephrectomized rats. [2010.05]

Effects of individual risk factors on the residual risk of cardiovascular events in a population of treated Chinese patients with hypertension: data from the Felodipine Event Reduction (FEVER) study. [2010]

[Effect of felodipine on the expression of NF-kappaB in rat model of atherosclerosis] [2009.09]

Preparation of N-maleoylchitosan nanocapsules for loading and sustained release of felodipine. [2009.07.13]

Felodipine downregulates serum interleukin-18 levels in rats with fructose-induced metabolic syndrome. [2009.04]

Pair distribution function X-ray analysis explains dissolution characteristics of felodipine melt extrusion products. [2009.04]

Extended release felodipine self-nanoemulsifying system. [2009]

[Curative effects on mild to moderate primary hypertension and influence on pulse wave velocity of slow releasing felodipine] [2008.11.18]

Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine. [2008.10]

Effect of poloxamer on the dissolution of felodipine and preparation of controlled release matrix tablets containing felodipine. [2008.08]

Felodipine reduces cardiac expression of IL-18 and perivascular fibrosis in fructose-fed rats. [2008.07]

The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy - A prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment. [2008.06.24]

The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy - A prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment. [2008.06.23]

Effect and tolerability of felodipine ER (Feloten) in the treatment of hypertension assessed by office blood pressure and home blood pressure. [2008.05]

Molecular mechanisms of felodipine suppressing atherosclerosis in high-cholesterol-diet apolipoprotein e-knockout mice. [2008.02]

Effects of extended-release felodipine on endothelial vasoactive substances in patients with essential hypertension. [2008]

[Efficacy, safety and tolerance of Felodipine controlled release tablets and Felodipine controlled release tablets associated combination therapy in the treatment of mild to moderate essential hypertension in China.] [2007.12.18]

[Preparation of transdermal drug delivery system of felodipine-metoprolol and its bioavailability in rabbits] [2007.11]

Different roles of pummelo furanocoumarin and cytochrome P450 3A5*3 polymorphism in the fate and action of felodipine. [2007.08]

[The FEVER (Felodipine EVEnt Reduction) trial; a randomised, double-blind, placebo-controlled trial in Chinese hypertensive patients] [2007.01]

Comparison in vitro felodipine release rate from the original versus generic product with controlled release of the drug. [2007]

Dihydropyridines, felodipine, and PHARMAC. [2005.07.15]

Felodipine-influenced gingival enlargement in an uncontrolled type 2 diabetic patient. [2005.07]

Desmopressin: in adults with nocturia. [2005]

Other possibly related research studies

Bimatoprost: a pharmacoeconomic review of its use in open-angle glaucoma and ocular hypertension. [2006]

[Evidence-based therapy of Raynaud's syndrome.] [2006.07]

[Grouping-related bias of effects of the same anti-hypertensive drugs in non-doubleblind randomized trials: a meta-analysis in Chinese hypertension clinical literature] [2006.05]

CACNA1C polymorphisms are associated with the efficacy of calcium channel blockers in the treatment of hypertension. [2006.04]

Drug-associated gingival enlargement: case report and review of aetiology, management and evidence-based outcomes of treatment. [2005]

[Toxicological analysis of selected 1,4-dihydropyridine calcium channel blockers in the diagnosis of intoxications] [2005.01]

Retrospective evaluation of a possible interaction between warfarin and levofloxacin. [2005.01]

Hypertension, possible vascular protection and lercanidipine. [2006.11]

Grapefruit juice and drug interactions. Exploring mechanisms of this interaction and potential toxicity for certain drugs. [2006.11]

Interaction of grapefruit juice and calcium channel blockers. [2006.07]

Asymmetric membrane capsules for delivery of poorly water-soluble drugs by osmotic effects. [2005.06.13]

Pharmacologic treatment of chronic pediatric hypertension. [2005]

Pharmacologic agents in the management of hypertension--nisoldipine coat-core. [2007.04]

A review of calcium channel antagonists in the treatment of pediatric hypertension. [2006]

Olmesartan medoxomil: current status of its use in monotherapy. [2006]

Determination of gambogic acid in dog plasma by high-performance liquid chromatography for a pharmacokinetic study. [2007.03]

Risk and predictability of drug interactions in the elderly. [2007]

Estimation of intragastric solubility of drugs: in what medium? [2007.05]

Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions. [2007.06]

The effect of ionizing radiation of 1,4-dihydropyridine derivatives in the solid state. [2007.05]

Determination and pharmacokinetics of manidipine in human plasma by HPLC/ESIMS. [2007.08]

Modeling gastrointestinal drug absorption requires more in vivo biopharmaceutical data: experience from in vivo dissolution and permeability studies in humans. [2007.10]

The influence of hydro-alcoholic media on hypromellose matrix systems. [2007.10]

A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity. [2008.03]

Drug metabolism enzyme expression and activity in primary cultures of human proximal tubular cells. [2008.02.03]

Concomitant calcium entry blockade and inhibition of the renin-angiotensin system: a rational and effective means for treating hypertension. [2008.03]

The application of glucose biosensor in studying the effects of insulin and anti-hypertensive drugs towards glucose level in brain striatum. [2008.07.15]

Effective and safe reduction of blood pressure with the combination of amlodipine 5 mg and valsartan 160 mg in hypertensive patients not controlled by calcium channel blocker monotherapy. [2008.05]

Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers. [2009.08]

Influence of grapefruit juice on the pharmacokinetics of diltiazem in Wistar rats upon single and multiple dosage regimens. [2009.08]

Mechanistic modeling of a magnetic marker monitoring study linking gastrointestinal tablet transit, in vivo drug release, and pharmacokinetics. [2009.07]

[Serum uric acid prevalence and changes post various antihypertensive agents in patients with essential hypertension] [2008.06]

Combination of amlodipine 10 mg and valsartan 160 mg lowers blood pressure in patients with hypertension not controlled by an ACE inhibitor/CCB combination. [2008]

[Effect of electroacupuncture on lipid metabolism in metabolic syndrome] [2010.09]

[Fixed combinations of antihypertensive medications--new opportunity in treatment of hypertension] [2010.03]

Generic substitution of commonly used medications: Australia-wide experience, 2007-2008. [2010.04.05]

Colonoscopic method for estimating the colonic absorption of extended-release dosage forms in dogs. [2010.06]

What can primary care prescribing data tell us about individual adherence to long-term medication?-comparison to pharmacy dispensing data. [2009.10]

[Effect of different combined antihypertensive regimen on the erectile function in male hypertensive patients]. [2011.07]

The effect of metoprolol alone and combined metoprolol-felodipin on the digital microcirculation of patients with primary Raynaud's syndrome. [2011.07]

Is a systolic blood pressure target <140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial. [2011.06]

Dynamic focal retinal arteriolar vasospasm in migraine. [2011.01]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017